Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of fibrosis using FXR ligands

Treatment of fibrosis using FXR ligands

US Patent 10258633 · Granted Apr 16, 2019

Estimated economic value: $33,352,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for the treatment of tumors2025
Pharmaceutical compositions for combination therapy2025
Farnesoid X receptor modulators2025
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase2025
TGR5 modulators and methods of use thereof2023
TGR5 modulators and methods of use thereof2022
Isoxazole as FXR receptor agonists2022
3-desoxy derivative and pharmaceutical compositions thereof2022
Pharmaceutical compositions for combination therapy2022
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase2022
Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/G2021
Methods and intermediates for the preparation of bile acid derivatives2021